D Kotz
Overview
Explore the profile of D Kotz including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
54
Citations
492
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Alayli A, Kotz D, Kastaun S
Subst Use Misuse
. 2022 Jun;
57(9):1417-1424.
PMID: 35686726
Background: Recreational cannabidiol (CBD) is frequently promoted as a medicinal or therapeutic cannabis product worldwide. Nationwide population-based data on awareness and use of recreational CBD are currently lacking. Objective: This...
2.
van Schayck O, Slok A, Kotz D, van Breukelen G, Chavannes N, Rutten-van Molken M, et al.
Ned Tijdschr Geneeskd
. 2016 Nov;
160:D955.
PMID: 27805538
Objective: Assessment of the effectiveness of the Assessment of Burden of COPD (ABC) tool on disease-specific quality of life in patients with Chronic Obstructive Pulmonary Disease (COPD). Design: Cluster-randomised controlled...
3.
van den Brand F, Nagelhout G, Winkens B, Evers S, Kotz D, Chavannes N, et al.
BMC Public Health
. 2016 Oct;
16(1):1056.
PMID: 27716132
Background: Stimulating successful tobacco cessation among employees has multiple benefits. Employees who quit tobacco are healthier, more productive, less absent from work, and longer employable than employees who continue to...
4.
van Rossem C, Spigt M, Smit E, Viechtbauer W, Mijnheer K, van Schayck C, et al.
Contemp Clin Trials
. 2015 Feb;
41:298-312.
PMID: 25657051
Introduction: Combining behavioural support and pharmacotherapy is most effective for smoking cessation and recommended in clinical guidelines. Despite that smoking cessation assistance from the general practitioner can be effective, dissemination...
5.
Gommans E, Even P, Linssen C, Van Dessel H, van Haren E, de Vries G, et al.
Respir Med
. 2014 Dec;
109(1):137-45.
PMID: 25464905
Background: Infections with non-tuberculous mycobacteria (NTM) represent an increasing problem. Their clinical relevance is still largely unknown as well as predictors for mortality in affected patients. The objective was to...
6.
Slenter R, Sprooten R, Kotz D, Wesseling G, Wouters E, Rohde G
Respiration
. 2012 Oct;
85(1):15-26.
PMID: 23037178
Background: Acute exacerbations of chronic obstructive pulmonary disease (AE-COPD) are related to high mortality, especially in hospitalized patients. Predictors for severe outcomes are still not sufficiently defined. Objectives: To assess...
7.
Kotz D, Brown J, West R
Drug Alcohol Depend
. 2012 Sep;
128(1-2):15-9.
PMID: 22943961
Background: Many different measures of motivation to stop smoking exist but it would be desirable to have a brief version that is standard for use in population surveys and for...
8.
Kotz D, Stapleton J, Owen L, West R
Tob Control
. 2010 May;
20(4):302-4.
PMID: 20472574
Objective: To obtain a more rigorous estimate of the cost-effectiveness of No Smoking Day (NSD), an annual UK-wide campaign to encourage smokers to quit, than has been possible hitherto. Design:...
9.
Kotz D, Vos R, Huibers M
J Med Ethics
. 2009 Sep;
35(9):534-40.
PMID: 19717691
Background: Spirometry for early detection of chronic obstructive pulmonary disease (COPD) and smoking cessation is criticised because of the potential negative effects of labelling with disease. Aim: To assess the...
10.
Kotz D, Wesseling G, Huibers M, van Schayck O
Eur Respir J
. 2009 Jan;
33(4):754-62.
PMID: 19129277
The objective of the present study was to test whether confronting smokers with previously undetected chronic obstructive pulmonary disease (COPD) increases the rate of smoking cessation. In total, 296 smokers...